Arrhythmias and ECG changes in life threatening hyperkalemia in older patients treated by potassium sparing drugs
Jazyk angličtina Země Česko Médium print-electronic
Typ dokumentu kazuistiky, časopisecké články
PubMed
23128820
DOI
10.5507/bp.2012.087
Knihovny.cz E-zdroje
- MeSH
- amilorid škodlivé účinky MeSH
- diuretika škodlivé účinky MeSH
- draslík krev MeSH
- elektrokardiografie MeSH
- hyperkalemie chemicky indukované patofyziologie terapie MeSH
- lidé MeSH
- monitorování léčiv MeSH
- senioři nad 80 let MeSH
- senioři MeSH
- srdeční arytmie etiologie MeSH
- Check Tag
- lidé MeSH
- mužské pohlaví MeSH
- senioři nad 80 let MeSH
- senioři MeSH
- ženské pohlaví MeSH
- Publikační typ
- časopisecké články MeSH
- kazuistiky MeSH
- Názvy látek
- amilorid MeSH
- diuretika MeSH
- draslík MeSH
BACKGROUND: Severe hyperkalemia is a life threatening condition that can cause fatal rhythm disturbance and terminal heart arrest. The most common cause of hyperkalemia in older patients is that of iatrogenic medication-related etiology due to associated polymorbidity, polypharmacy and reduced reserve metabolic capacity. The aim of this paper is to increase awareness in the clinicians of the risk of hyperkalemia in elderly patients treated by potassium sparing drugs. METHODS AND RESULTS: We present two case reports of hyperkalemia ≥ 9.0 mmol/L induced by potassium sparing medications with cardiac arrhythmias and severe ECG changes including atrial asystole, disturbance of intraventricular conduction and morphological changes such as tenting T waves and deformed wide QRS complexes. The most frequent causes of hyperkalemia in elderly patients are discussed and electrocardiogram changes and arrhythmias in hyperkalemia are analyzed, as well as their treatment and prevention. CONCLUSION: Potassium sparing drug therapy in older persons requires more frequent monitoring especially when drugs or their doses are changed, or during concomitant acute illness.
Citace poskytuje Crossref.org